839713-95-0

Upstream product

• 868529-50-4 N-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxyphenyl]-acetamide 
• 51410-09-4 acetic acid-(3-acetyl-4-methoxy-anilide) 
• 868529-49-1 3-dimethylamino-1-(2'-methoxy-5'-acetamidophenyl)prop-2-en-1-one 
• 839714-89-5 N-[4-methoxy-3-(2-methyl-2H-pyrazol-3-yl)phenyl]-acetamide 
• 720702-43-2 5-(2-methoxy-5-nitro-phenyl)-1-methyl-1H-pyrazole 

Downstream Products

• 839713-36-9 Nelotanserin 

Relevant academic research and scientific papers

3-Phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto

The present invention relates to certain 3-phenyl-pyrazole derivatives of Formula (Ia) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical compositions thereof are di

PROCESSES FOR PREPARING SUBSTITUTED N-ARYL-N’-[3-(1H-PYRAZOL-5-YL) PHENYL] UREAS AND INTERMEDIATES THEREOF

The present invention is directed to processes for the preparation of substituted phenylpyrazole ureas of Formula (I), that are useful as 5-HT2A serotonin receptor modulators for the treatment of disease.

DIARYL AND ARYLHETEROARYL UREA DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERTO

The present invention relates to certain pyrazole derivatives of Formula (I) and pharmaceutical compositions thereof that modulate the activity of the 5-HT2A serotonin receptor. Compounds and pharmaceutical compositions thereof are directed to